Thyroid Cancer Trial, Recruiting (NCT06733753)

Thyroid Cancer Trial, Recruiting NCT06733753 Sponsor: Chinese PLA General Hospital Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06733753 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had a needle biopsy of your thyroid that came back with an uncertain result (classified as "Bethesda III or IV"), and a specific genetic test (BRAF V600E) came back negative
Scans and imaging (ultrasound and CT scans of the neck and chest) show no signs that the thyroid condition has spread beyond the thyroid, to nearby lymph nodes, or to other parts of the body
You have either chosen not to have surgery or have been told you are not a suitable candidate for surgery
You have been monitored and followed up by your medical team for at least 12 months

Who may not be able to join:

Your biopsy results showed a follicular neoplasm (a specific type of growth) or confirmed cancer findings
Your ultrasound did not show any suspicious signs that might suggest cancer
You have paralysis of the vocal cord on the opposite side of the thyroid being treated (confirm with trial site)
You have been followed up by your medical team for less than 12 months

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yukun Luo, Chinese PLA General Hospital

Phone: 13811237313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06733753

Sponsor: Chinese PLA General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 13811237313

More information: https://clinicaltrials.gov/study/NCT06733753

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had a needle biopsy of your thyroid that came back with an uncertain result (classified as "Bethesda III or IV"), and a specific genetic test (BRAF V600E) came back negative
Scans and imaging (ultrasound and CT scans of the neck and chest) show no signs that the thyroid condition has spread beyond the thyroid, to nearby lymph nodes, or to other parts of the body
You have either chosen not to have surgery or have been told you are not a suitable candidate for surgery
You have been monitored and followed up by your medical team for at least 12 months

Who may not be able to join:

Your biopsy results showed a follicular neoplasm (a specific type of growth) or confirmed cancer findings
Your ultrasound did not show any suspicious signs that might suggest cancer
You have paralysis of the vocal cord on the opposite side of the thyroid being treated (confirm with trial site)
You have been followed up by your medical team for less than 12 months

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chinese PLA General Hospital

Registry

ClinicalTrials.gov

Start date

9 December 2024

Est. completion

31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

volume reduction rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov